Abstract
Until now viral and bacterial acute intestinal infections have a high percent in the whole structure of modern intestinal disorders morbidity. Taking into consideration inefficacy of antibacterial treatment in a number of cases, probiotics with antagonist effect on a wide range of bacteria have found a wide usage. This study proves clinic and morphological efficacy of large doses Bifidumbacterinum forte for the treatment of the diseases mentioned. The patients of the test group demonstrated a relation dyspeptic disturbances, improvement of total state in a shorter period than the patients of control group.
Publication types
-
Clinical Trial
-
Comparative Study
-
English Abstract
MeSH terms
-
Acute Disease
-
Adult
-
Anti-Bacterial Agents / administration & dosage*
-
Antiviral Agents / administration & dosage*
-
Bifidobacterium*
-
Biological Products / administration & dosage*
-
Chronic Disease
-
Dose-Response Relationship, Drug
-
Female
-
Gastrointestinal Diseases / drug therapy*
-
Gastrointestinal Diseases / microbiology
-
Hepatitis B / drug therapy*
-
Hepatitis B / microbiology
-
Humans
-
Intestinal Diseases / drug therapy*
-
Intestinal Diseases / microbiology
-
Male
-
Probiotics / administration & dosage*
-
Time Factors
Substances
-
Anti-Bacterial Agents
-
Antiviral Agents
-
Biological Products
-
bifidobacterin